Siemens gets FDA nod for Intevo SPECT/CT
Article Thumbnail ImageSeptember 5, 2013 -- Siemens Healthcare has garnered U.S. Food and Drug Administration 510(k) clearance for its Symbia Intevo SPECT/CT system.

To get access to this article and all of the content on, create a free account or sign-in now.

Member Sign In:
MemberID or E-mail Address:  
Do you have a password?
No, I want a free membership.
Yes, I have a password:  

Intevo, the first member of Siemens' xSPECT product family, integrates data from both SPECT and CT modalities and generates high-resolution as well as quantitative SPECT images, according to the vendor.

Siemens has also included its CARE Dose4D technique, which can reduce patient CT radiation dose by up to 68%, while the system's Autoform collimator captures up to 26% more photon counts from radiotracer activity, according to the vendor.

Siemens first unveiled Intevo at the Society of Nuclear Medicine and Molecular Imaging (SNMMI) meeting in June.